Dear Colleagues and Guests The field of preclinical and clinical lymphoma research has seen a dramatic acceleration of progress during the last years, ranging from a molecular characterization of the disease to the development of novel mouse models, as well as preclinical drug development, ultimately cumulating in massive alterations of our current treatment algorithms, now […]

Dear Colleagues and Guests The field of preclinical and clinical lymphoma research has seen a dramatic acceleration of progress during the last years, ranging from a molecular characterization of the disease to the development of novel mouse models, as well as preclinical drug development, ultimately cumulating in massive alterations of our current treatment algorithms, now […]